Search

everythinglearnresearchcommunity

for

Search:↓

Thermal imaging is a useful non-invasive method to diagnose active inflammation in frontal fibrosing alopecia.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Early treatment and multidisciplinary care are key to managing Frontal Fibrosing Alopecia and preventing further hair loss.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

FFA patients have fewer melanocytes and thinner skin compared to others.

More inclusive research is needed to effectively treat frontal fibrosing alopecia in Black patients.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

AFL is safe and effective for topical drug delivery but needs larger studies and cheaper devices for wider use.

The protein FLCN is involved in cellular cleanup and is regulated by ULK1.

Increased sunscreen use may be linked to frontal fibrosing alopecia in Hispanic females.

The Fas/FasL pathway may play a role in alopecia areata.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Rubbing or pressing on the face can cause small bumps, and changing posture along with certain creams can improve them.

5-α-reductase inhibitors, intralesional steroids, and hydroxychloroquine are the most effective treatments for frontal fibrosing alopecia.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

FFA can be mistaken for rosacea, requiring specific treatment for accurate diagnosis and management.